Related Experiment Video

Updated: May 25, 2026

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on: September 10, 2014

Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches

Cristóbal Aguilar-Gallardo1, Emily Cecilia Rutledge, Ana M Martínez-Arroyo

  • 1Valencia Node of the Spanish Stem Cell Bank, Prince Felipe Research Centre (CIPF), Valencia, Spain.

Stem Cell Reviews and Reports
|January 27, 2012
PubMed

Insights

New ovarian cancer therapies focus on cancer stem cells to overcome chemoresistance and prevent metastasis. Individualized treatment strategies combining novel targets and stem cell modulation offer future hope for effective ovarian cancer treatment.

Area of Science:

  • Oncology
  • Cancer Stem Cell Biology
  • Genetics and Molecular Mechanisms

Background:

  • Ovarian cancer research aims to improve therapy for residual disease post-surgery and chemotherapy.
  • Cancer stem cells (CSCs) present a significant challenge due to chemoresistance and metastatic potential.
  • Understanding CSCs is crucial for developing more effective ovarian cancer treatments.

Purpose of the Study:

  • To review novel therapeutic strategies for ovarian cancer based on CSC research.
  • To explore CSC-driven chemoresistance, metastasis prevention, and individualized therapy approaches.
  • To identify optimal treatment combinations for human ovarian cancer.

Main Methods:

  • Literature review of novel treatment approaches for ovarian cancer stem cells (1993-2011).
  • Analysis of studies focusing on CSCs, chemoresistance, metastasis, and individualized therapy.
  • Synthesis of findings on therapeutic strategies targeting CSCs.

Main Results:

  • The cancer stem cell model is central to understanding ovarian cancer treatment complexities.
  • Novel strategies involve targeting CSCs, preventing metastasis, and tailoring treatments.
  • Enhancing existing therapies and targeting new pathways are key.

Conclusions:

  • Future ovarian cancer treatment relies on individualized systems.
  • Strategies include enhancing current treatments, targeting novel pathways, inducing CSC differentiation, and regulating signaling.
  • Effective combination therapies are essential for treating human ovarian cancer.

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...